Medical Research Consultants I is categorized under Business Consultants in Portland, OR and active since 2006.
Medical Research Consultants I was established in 2006, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Business Consultants business, which does work in the B2B market, and is classified as a Business Consultants, under code number 541618 by the NAICS.
If you are seeking more information, feel free to contact Claudia K Rosemont at the company’s single location by writing to 1260 Nw Nto Parkway U 406, Portland, Oregon OR 97209 or by phoning (503) 358-3269. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Medical Research Consultants I |
| Contact Person: | Claudia K Rosemont |
| Address: | 1260 Nw Nto Parkway U 406, Portland, Oregon 97209 |
| Phone Number: | (503) 358-3269 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2006 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Business Consultants |
| SIC Code: | 8748 |
| NAICS Code: | 541618 |
| Share This Business: |
Medical Research Consultants I was started in 2006 to provide professional Business Consultants under the SIC code 8748 and NAICS code 541618. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Claudia K Rosemont for inquiries that concern Medical Research Consultants I by calling the company number (503) 358-3269, as your correspondence is most welcome. Additionally, the physical location of the single location of Medical Research Consultants I can be found at the coordinates 45.526545,-122.615061 as well as the street address 1260 Nw Nto Parkway U 406 in Portland, Oregon 97209.
For its online presence, you may visit Medical Research Consultants I’s website at and engage with its social media outlets through on Twitter and on Facebook.